
    
      A multicenter, randomized, double-blind, parallel group, placebo controlled study to
      investigate the effects of salmeterol/fluticasone 50/500mcg bd, salmeterol 50mcg bd, and
      fluticasone 500mcg bd, all delivered via the DISKUS/ACCUHALER inhaler, on the survival of
      subjects with chronic obstructive pulmonary disease over 3 years of treatment.
    
  